425
Views
30
CrossRef citations to date
0
Altmetric
Review

Migraine treatment and placebo effect

, &
Pages 413-419 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (29)

Hauke Basedau, Raffaele Ornello, Eleonora De Matteis, Bolortsetseg Davaasuren, Begimai Kadyrova, Doga Vuralli, Myroslav Bozhenko, Ilaha Azizova, Natia Bitsadze, Elnura Eralieva, Messoud Ashina, Dimos Mitsikostas & Francesca Puledda. (2023) Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?. Cephalalgia 43:12.
Crossref
Chengyi Sun, Zhiyi Xiong, Chongyang Sun, Tinglan Liu, Xiaoyu Liu, Qinhong Zhang, Baoyan Liu, Shiyan Yan & Cunzhi Liu. (2023) Placebo response in sham-acupuncture–controlled trials for migraine: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice 53, pages 101800.
Crossref
Serkan Aksu, Tuba Cerrahoğlu Şirin, Buse Rahime Hasırcı Bayır, Çağrı Ulukan, Ahmet Zihni Soyata, Adnan Kurt, Sacit Karamürsel & Betül Baykan. (2023) Long-Term Prophylactic Transcranial Direct Current Stimulation Ameliorates Allodynia and Improves Clinical Outcomes in Individuals With Migraine. Neuromodulation: Technology at the Neural Interface 26:4, pages 778-787.
Crossref
Michele Trimboli, Oreste Marsico, Letizia Troisi & Francesco Fasano. (2023) External trigeminal neurostimulation in patients with chronic migraine. Pain Management.
Crossref
José Manuel Valdueza, Jens Peter Dreier, Johannes Woitzik, Christian Dohmen, Oliver Sakowitz, Johannes Platz, Stefanie Leistner-Glaess & Victoria Dorothea Witt. (2022) Course of Preexisting Migraine Following Spontaneous Subarachnoid Hemorrhage. Frontiers in Neurology 13.
Crossref
Juliana Homem Padilha Spavieri & Pablo Guarisco Ferreira. (2022) The importance of considering psychosocial aspects in migraine patients. Headache Medicine 12:4, pages 329-330.
Crossref
Halina M. ZyczynskiHolly E. RichterVivian W. SungEmily S. LukaczLily A. AryaDavid D. RahnAnthony G. ViscoDonna MazloomdoostBenjamin CarperMarie G. Gantz. (2022) Percutaneous Tibial Nerve Stimulation vs Sham Stimulation for Fecal Incontinence in Women: NeurOmodulaTion for Accidental Bowel Leakage Randomized Clinical Trial. American Journal of Gastroenterology 117:4, pages 654-667.
Crossref
Katharina Schmidt, Tobias Berding, Julian Kleine-Borgmann, Harald Engler, Dagny Holle-Lee, Charly Gaul & Ulrike Bingel. (2022) The beneficial effect of positive treatment expectations on pharmacological migraine prophylaxis. Pain 163:2, pages e319-e327.
Crossref
Katharina Schmidt, Julian Kleine-Borgmann, Dagny Holle-Lee, Charly Gaul & Ulrike Bingel. (2021) Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial. BMJ Open 11:6, pages e045969.
Crossref
Faraidoon Haghdoost & Simona Sacco. (2023) Comment on ‘Clopidogrel Can be An Effective Complementary Prophylactic for Drug-Refractory Migraine with Patent Foramen Ovale’. Journal of Investigative Medicine 69:2, pages 411-412.
Crossref
Timothy R. Smith, Marina Janelidze, George Chakhava, Roger Cady, Joe Hirman, Brent Allan, Susan Pederson, Jeff Smith & Barbara Schaeffler. (2020) Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study. Clinical Therapeutics 42:12, pages 2254-2265.e3.
Crossref
Corissa Piatka & Robert D. Beckett. (2019) Propofol for Treatment of Acute Migraine in the Emergency Department: A Systematic Review. Academic Emergency Medicine 27:2, pages 148-160.
Crossref
Laís Bhering Martins, Ana Maria dos Santos Rodrigues, Nayara Mussi Monteze, Jenneffer Rayane Braga Tibaes, Matheus Henrique Alves Amaral, Rodrigo Santiago Gomez, Antônio Lúcio Teixeira & Adaliene Versiani Matos Ferreira. (2019) Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc. ) in the prophylactic treatment of migraine . Cephalalgia 40:1, pages 88-95.
Crossref
Stoyan PopkirovStoyan Popkirov. 2020. Funktionelle neurologische Störungen. Funktionelle neurologische Störungen 185 192 .
Karen M. von Deneen, Ling Zhao & Jixin Liu. (2020) Individual differences of maladaptive brain changes in migraine and their relationship with differential effectiveness of treatments. Brain Science Advances 5:4, pages 239-255.
Crossref
Jim Odell, Carol Clark, Adrian Hunnisett, Osman Hassan Ahmed & Jonathan Branney. (2019) Manual therapy for chronic migraine: a pragmatic randomised controlled trial study protocol. Chiropractic & Manual Therapies 27:1.
Crossref
Mario F.P. Peres, Arão Belitardo Oliveira, Juliane P. Mercante, Helder H. Kamei, Patricia R. Tobo, Todd D. Rozen, Morris Levin, Dawn C. Buse & Giancarlo Lucchetti. (2019) Optimism, Pessimism, and Migraine: A Cross-Sectional, Population-Based Study. Headache: The Journal of Head and Face Pain 59:2, pages 205-214.
Crossref
Eva Bruloy, Raphael Sinna, Jean-Louis Grolleau, Apolline Bout-Roumazeilles, Emilie Berard & Benoit Chaput. (2019) Botulinum Toxin versus Placebo. Plastic and Reconstructive Surgery 143:1, pages 239-250.
Crossref
Aleksander Chaibi, Heidi Knackstedt, Peter J. Tuchin & Michael Bjørn Russell. (2017) Chiropractic spinal manipulative therapy for cervicogenic headache: a single-blinded, placebo, randomized controlled trial. BMC Research Notes 10:1.
Crossref
Angèle Guilbot, Marie Bangratz, Samira Ait Abdellah & Christian Lucas. (2017) A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complementary and Alternative Medicine 17:1.
Crossref
Simona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, Michela Maria Cainazzo, Andrea Negro, Paolo Martelletti & Luigi Alberto Pini. (2017) Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy. Frontiers in Neurology 8.
Crossref
L. Siproudhis, W. Graf, A. Emmanuel, D. Walker, R. Ng Kwet Shing, C. Pediconi, J. Pilot, S. Wexner & J. Scholefield. (2016) Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response. International Journal of Colorectal Disease 31:6, pages 1205-1216.
Crossref
Antonio Russo, Alessandro Tessitore, Francesca Conte, Laura Marcuccio, Alfonso Giordano & Gioacchino Tedeschi. (2015) Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experience. The Journal of Headache and Pain 16:1.
Crossref
Marcelo Moraes Valença, Amanda Araújo da Silva & Carlos Alberto Bordini. (2015) Headache Research and Medical Practice in Brazil: An Historical Overview. Headache: The Journal of Head and Face Pain 55, pages 4-31.
Crossref
Adriana B Conforto, Edson AmaroJrJr, André L Gonçalves, Juliane PP Mercante, Vera Z Guendler, Josione R Ferreira, Clara CFB Kirschner & Mario FP Peres. (2013) Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine. Cephalalgia 34:6, pages 464-472.
Crossref
Espen Saxhaug Kristoffersen, Kjersti Aaseth, Ragnhild Berling Grande, Christofer Lundqvist & Michael Bjørn Russell. (2013) Self-reported efficacy of complementary and alternative medicine: the Akershus study of chronic headache. The Journal of Headache and Pain 14:1.
Crossref
Usha K. Misra, Jayantee Kalita & Sanjeev K. Bhoi. (2013) High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: a randomized, placebo-controlled study. Journal of Neurology 260:11, pages 2793-2801.
Crossref
Morris Maizels, Sheena Aurora & Mary Heinricher. (2012) Beyond Neurovascular: Migraine as a Dysfunctional Neurolimbic Pain Network. Headache: The Journal of Head and Face Pain 52:10, pages 1553-1565.
Crossref
Tobias Kurth, Hugues Chabriat & Marie-Germaine Bousser. (2012) Migraine and stroke: a complex association with clinical implications. The Lancet Neurology 11:1, pages 92-100.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.